SlideShare a Scribd company logo
1 of 14
Structure prediction with FAMS for proteins
  screened critically to autoimmune diseases
          based upon bioimformatics

Shigeharu Ishida (Dept. Phys., Chuo Uinv.)
Hideaki Umeyama (Dept. Bio. Sci., Chuo Univ.)
Mitsuo Iwadate (Dept. Bio. Sci., Chuo Univ.)
Y-h. Taguchi (Dept. Phys., Chuo Uinv.)
1. Introduction

Autoimmune disease:
“Autoimmune disease arise from an
inappropriate immune response of the body
against substances and tissues normally
present in the body.”

Ex.
Rheumatoid Arthritis (RA; 関節リウマチ)
Alopecia areata (円形脱毛症)
2. Previous findings …
 B. M. Javierre et al (2010)
 Genome Res. 20[2] pp 170-179

Target:
Systemic lupus erythematosus
(SLE;全身性エリテマトーデス )
RA
Dermatomyositis (DM;皮膚筋炎 )

Seek common promoter methylation
→ SLE Only
Y-h. Taguchi, DMSM2010 (2010)
http://www.ai-gakkai.or.jp/jsai/sig/dmsm/012/

Successfully picked up 33 promoters commonly
methylated for RA, SLE, and DM.

But, no biological validations …..
Data base : ☓ , Blast : ☓

In this paper, we show that protein structure
prediction by FAMS is useful tool for functional
 annotation of proteins and also possibly useful
for drug discovery...
3. FAMS (Full Automatic Modeling System)

“The computer program FAMS performs
homology modeling of protein structures by
means of an algorithm consisting of database
searches and simulated annealing.”

Umeyama & Iwadate (2004)
Curr Protoc Bioinformatics.
4. Results
Reference                                              Model
genesymbol     PDBID    P-value        gene symbol
AIM2          2OQ0_B          4.00E-92 GAMMA-INTERFERON-INDUCIBLE PROTEIN IFI-16
CARD15        3CIY_B          7.00E-64 TOLL-LIKE RECEPTOR 4, VARIABLE LYMPHOCYTE (TLR4)
CD82          2BG9_A          4.60E-01 ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA CHAIN
CSF1R         3B43_A          5.00E-83 TITIN
CSF3         1GNC_A           2.00E-66 GRANULOCYTE COLONY-STIMULATING FACTOR
CSF3R        3DMK_A           1.00E-71 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM)
DHCR24       2Q4W_A         1.00E-115 CYTOKININ DEHYDROGENASE 7 (CKO7)
ERCC3         2W74_D        1.00E-152 TYPE I RESTRICTION ENZYME ECOR124IIR PROTEIN (HSDR)
GRB7          3HK0_B          2.00E-73 GROWTH FACTOR RECEPTOR-BOUNDP ROTEIN10 (GRB10)
HGF           2F83_A        1.00E-111 COAGULATION FACTOR XI
HOXB2         2D5V_A          9.00E-24 HEPATOCYTE NUCLEAR FACTOR 6 (HNF-6)
IFNGR2        1FNF_A          1.00E-37 FIBRONECTIN
LCN2          1X71_A          1.00E-51 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL)
LMO2          2XJY_A          2.00E-33 RHOMBOTIN-2
LTB4R         2KS9_A          2.00E-83 SUBSTANCE-P RECEPTOR
MMP14         1SU3_B        1.00E-160 INTERSTITIAL COLLAGENASE (MMP-1)
MMP8          1SU3_B        1.00E-171 INTERSTITIAL COLLAGENASE (MMP-1)
MPL           3L5H_A          4.00E-63 INTERLEUKIN-6 RECEPTOR SUBUNIT BETA (IL6RB)
PAD14        2DEW_ X         0.00E+00 PROTEIN-ARGININE DEIMINASE TYPE IV
PECAM1       3DMK_A         1.00E-104 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM)
PI3          1TWP_A           2.00E-19 WHEY ACIDIC PROTEIN (WAP)
RARA          3DZY_A          4.00E-95 RETINOIC ACID RECEPTOR RXR-ALPHA
S100A2        2RGI_A          4.00E-19 PROTEIN S100-A2
SEPT9         3FTQ_A        1.00E-137 SEPTIN-2
SLC22A18      1PW4_A        1.00E-108 GLYCEROL-3-PHOSPHATE TRANSPORTER
SPI1          1GVJ_B          1.00E-21 C-ETS-1 PROTEIN (ETS1)
SPP1          1D2T_A          3.00E-14 ACID PHOSPHATASE (ACP)
STAT5A       1Y1U_ A         0.00E+00 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT5A
SYK           2OZO_A        1.00E-168 TYROSINE-PROTEIN KINASE ZAP-70
TIE1         3DMK_A           2.00E-84 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM)
TM7SF3       [1AR1_A]         6.00E-88 CYTOCHROME C OXIDASE
TRIP6         1B8T_A          2.00E-32 CYSTEINE-RICH PROTEIN1 (CRP1)
VAMP8        2KOG_A           1.00E-21 VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 (VAMP2)
・Almost all proteins are modeled with very
small P-values (〜10E-20) (with high
significance)

・Obtained proteins have functional annotations
(because they are listed in PDB)

⇒ Protein structure prediction by FAMS turns
out to be also useful for functional annotation,
because model protein registered in PDB is often
well studied and annotated. (Otherwise none
hope to decide 3D structure with much effort and
money!)
・Almost all functional annotations are
related to immunology/autoimmune
                      ⇓
33 selected promoters turned out to be
biologically meaningful

         e.g., AIM2 modeled by IFI-16

         “Structures of the HIN Domain: DNA
         Complexes Reveal Ligand Binding and
         Activation Mechanisms of the AIM2
         Inflammasome and IFI16 Receptor”
         Jin et al (2012/4/20) Immunity.
5. To Drug Discovery...
5.1 Ligand Search
mmp8/14 are modeled by mmp1. Ligand designed
for mmp1 possibly can bind to mmp8/14, too.

     mmp8                      mmp14
5.2 Search for protein complex




Protein A        Protein Complex   Protein B
                      in PDB




            Protein Complex Candidate
Huge number of protein complex candidates were
found....

         CSF1R




PECAM1   410
CSF1R vs PECAM1 modeled by 2ZJS
Why protein complex?


If we can terminate protein complex
formation by finding molecules to bind
interface between two proteins, they can be
drug.
6. Conclusion

・FAMS predicts protein structure of genes
whose promoter are commonly de/methylated
for autoimmune.
・Protein structure prediction is useful for
functional annotation
・It also helps ligand search
・ FAMS is also useful protein complex
inference which may lead to drug discovery

More Related Content

What's hot

Angiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology AnalysisAngiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology AnalysisLarry Norder
 
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase  (TPMT) variantsBiophysical studies of Thiopurine S-methyltransferase  (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variantsPaolo Dametto
 
TGR5 (GPBAR1) and intestinal immunity
TGR5 (GPBAR1) and intestinal immunityTGR5 (GPBAR1) and intestinal immunity
TGR5 (GPBAR1) and intestinal immunityAttività scientifica
 
Top 200 Pharmaceutical Drugs by Retail Sales
Top 200 Pharmaceutical Drugs by Retail Sales Top 200 Pharmaceutical Drugs by Retail Sales
Top 200 Pharmaceutical Drugs by Retail Sales Sandeep Mishra
 
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...Covance
 
Poster - Sylvia Cheung
Poster - Sylvia CheungPoster - Sylvia Cheung
Poster - Sylvia CheungSylvia Cheung
 
Prof Stefano Fiorucci - FXR and liver fibrosis
Prof Stefano Fiorucci -  FXR and liver fibrosisProf Stefano Fiorucci -  FXR and liver fibrosis
Prof Stefano Fiorucci - FXR and liver fibrosisAttività scientifica
 
The mdr project
The mdr projectThe mdr project
The mdr projectSelim78
 
Elisa kits for children rheumatoid arthritis research
Elisa kits for children rheumatoid arthritis researchElisa kits for children rheumatoid arthritis research
Elisa kits for children rheumatoid arthritis researchElabscience
 
13.elisa kits for aplastic anemia research
13.elisa kits for aplastic anemia research13.elisa kits for aplastic anemia research
13.elisa kits for aplastic anemia researchElabscience
 

What's hot (16)

Angiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology AnalysisAngiotensin Rennin Polypharmacology Analysis
Angiotensin Rennin Polypharmacology Analysis
 
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase  (TPMT) variantsBiophysical studies of Thiopurine S-methyltransferase  (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
 
TGR5 (GPBAR1) and intestinal immunity
TGR5 (GPBAR1) and intestinal immunityTGR5 (GPBAR1) and intestinal immunity
TGR5 (GPBAR1) and intestinal immunity
 
Top 200 Pharmaceutical Drugs by Retail Sales
Top 200 Pharmaceutical Drugs by Retail Sales Top 200 Pharmaceutical Drugs by Retail Sales
Top 200 Pharmaceutical Drugs by Retail Sales
 
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...
In Vitro Metabolic, CYP and Transporter Characterization of PTI-125, a Novel ...
 
DTEx 02042009
DTEx 02042009DTEx 02042009
DTEx 02042009
 
Mb cardiovascular
Mb cardiovascularMb cardiovascular
Mb cardiovascular
 
Poster - Sylvia Cheung
Poster - Sylvia CheungPoster - Sylvia Cheung
Poster - Sylvia Cheung
 
Prof Stefano Fiorucci - FXR and liver fibrosis
Prof Stefano Fiorucci -  FXR and liver fibrosisProf Stefano Fiorucci -  FXR and liver fibrosis
Prof Stefano Fiorucci - FXR and liver fibrosis
 
The mdr project
The mdr projectThe mdr project
The mdr project
 
Poster Presentation
Poster PresentationPoster Presentation
Poster Presentation
 
Hpv Slide
Hpv SlideHpv Slide
Hpv Slide
 
Genetics
GeneticsGenetics
Genetics
 
Elisa kits for children rheumatoid arthritis research
Elisa kits for children rheumatoid arthritis researchElisa kits for children rheumatoid arthritis research
Elisa kits for children rheumatoid arthritis research
 
Antiperspirant ~oli
Antiperspirant ~oliAntiperspirant ~oli
Antiperspirant ~oli
 
13.elisa kits for aplastic anemia research
13.elisa kits for aplastic anemia research13.elisa kits for aplastic anemia research
13.elisa kits for aplastic anemia research
 

Similar to Structure prediction with FAMS for proteins screened critically to autoimmune diseases based upon bioimformatics

Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyChris Southan
 
Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controllerYumi Saiki
 
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy Gately
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy GatelyTargeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy Gately
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy GatelyHannahMcCarthy31
 
Matt_Duncton_Bioorg_Med_Chem_2009
Matt_Duncton_Bioorg_Med_Chem_2009Matt_Duncton_Bioorg_Med_Chem_2009
Matt_Duncton_Bioorg_Med_Chem_2009Leon Smith
 
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP® Systems
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition Ahmed Allam
 
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...1901 Atos das Policias Internacionais
 
Novel amphiphilic nanoparticles for controlled and sustained release
Novel amphiphilic nanoparticles for controlled and sustained releaseNovel amphiphilic nanoparticles for controlled and sustained release
Novel amphiphilic nanoparticles for controlled and sustained releaseTomsk Polytechnic University
 
Discovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsDiscovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsLiwei Chen
 
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
Oncodesign aacr 2018   development of a high throughput in vitro screening pl...Oncodesign aacr 2018   development of a high throughput in vitro screening pl...
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...Florence Fombertasse
 
My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007Jovana Grbic
 
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...Ann-Marie Roche
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...bioejjournal
 
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...bioejjournal
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...bioejjournal
 

Similar to Structure prediction with FAMS for proteins screened critically to autoimmune diseases based upon bioimformatics (20)

Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
 
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando FloridaCristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
 
Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controller
 
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy Gately
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy GatelyTargeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy Gately
Targeting PIM kinase to overcome drug resistance in NSCLC - Dr Kathy Gately
 
Matt_Duncton_Bioorg_Med_Chem_2009
Matt_Duncton_Bioorg_Med_Chem_2009Matt_Duncton_Bioorg_Med_Chem_2009
Matt_Duncton_Bioorg_Med_Chem_2009
 
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition
 
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
 
Amphiphilic nanocarriers
Amphiphilic nanocarriersAmphiphilic nanocarriers
Amphiphilic nanocarriers
 
Novel amphiphilic nanoparticles for controlled and sustained release
Novel amphiphilic nanoparticles for controlled and sustained releaseNovel amphiphilic nanoparticles for controlled and sustained release
Novel amphiphilic nanoparticles for controlled and sustained release
 
Discovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsDiscovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitors
 
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
Oncodesign aacr 2018   development of a high throughput in vitro screening pl...Oncodesign aacr 2018   development of a high throughput in vitro screening pl...
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
 
Drug screening
Drug screeningDrug screening
Drug screening
 
Mb cell death-apoptosis
Mb cell death-apoptosisMb cell death-apoptosis
Mb cell death-apoptosis
 
My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007
 
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...
Identifying candidate targets for Cancer Therapy with Integrated Text Mining ...
 
Ap2 Alpha
Ap2 AlphaAp2 Alpha
Ap2 Alpha
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...
 
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...
 

More from Y-h Taguchi

Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Y-h Taguchi
 
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明Y-h Taguchi
 
Tensor decomposition­based unsupervised feature extraction identified the un...
Tensor decomposition­based unsupervised  feature extraction identified the un...Tensor decomposition­based unsupervised  feature extraction identified the un...
Tensor decomposition­based unsupervised feature extraction identified the un...Y-h Taguchi
 
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Y-h Taguchi
 
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発Y-h Taguchi
 
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Y-h Taguchi
 
Rectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataRectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataY-h Taguchi
 
テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択Y-h Taguchi
 
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索Y-h Taguchi
 
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定Y-h Taguchi
 
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定Y-h Taguchi
 
Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Y-h Taguchi
 
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...Y-h Taguchi
 
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Y-h Taguchi
 
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析Y-h Taguchi
 
PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定Y-h Taguchi
 
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...Y-h Taguchi
 
A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...Y-h Taguchi
 
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定Y-h Taguchi
 
Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Y-h Taguchi
 

More from Y-h Taguchi (20)

Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...Tensor decomposition based and principal component analysis based unsupervise...
Tensor decomposition based and principal component analysis based unsupervise...
 
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
主成分分析を用いた教師なし学習による筋萎縮性側索硬化症とがんの遺伝的関連性の解明
 
Tensor decomposition­based unsupervised feature extraction identified the un...
Tensor decomposition­based unsupervised  feature extraction identified the un...Tensor decomposition­based unsupervised  feature extraction identified the un...
Tensor decomposition­based unsupervised feature extraction identified the un...
 
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...Tensor decomposition ­based unsupervised feature extraction applied to matrix...
Tensor decomposition ­based unsupervised feature extraction applied to matrix...
 
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
遺伝子発現プロファイルからの 薬剤標的タンパクの統計的推定法の開発
 
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
Identification of Candidate Drugs for Heart Failure using Tensor Decompositio...
 
Rectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics dataRectified factor networks for biclustering of omics data
Rectified factor networks for biclustering of omics data
 
テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択テンソル分解を用いた教師なし学習による変数選択
テンソル分解を用いた教師なし学習による変数選択
 
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
主成分分析を用いた教師なし学習による変数選択を用いたヒストン脱アセチル化酵素阻害剤の機能探索
 
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
『主成分分析を用いた教師なし学習による変数選択』 を用いたデング出血熱原因遺伝子の推定
 
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
miRNA-mRNA相互作用同定を用いた 腎芽腫関連遺伝子の推定
 
Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...Principal component analysis based unsupervised feature extraction applied to...
Principal component analysis based unsupervised feature extraction applied to...
 
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...microRNA-mRNA interaction identification in Wilms tumor using principal compo...
microRNA-mRNA interaction identification in Wilms tumor using principal compo...
 
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
Comprehensive analysis of transcriptome andmetabolome analysis in Intrahepati...
 
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
主成分分析を用いた教師なし学習による出芽酵母 の時間周期遺伝子発現プロファイルの解析
 
PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定PCAを用いた2群の有意差検定
PCAを用いた2群の有意差検定
 
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...SFRP1 is a possible candidate for epigenetic  therapy in non­small cell lung ...
SFRP1 is a possible candidate for epigenetic therapy in non­small cell lung ...
 
A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...A cross-species bi-clustering approach to identifying conserved co-regulated ...
A cross-species bi-clustering approach to identifying conserved co-regulated ...
 
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
主成分分析を用いた教師なし学習による変数選択法を用いたがんにおけるmRNA-miRNA相互作用のより信頼性のある同定
 
Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...Identification of aberrant gene expression associated with aberrant promoter ...
Identification of aberrant gene expression associated with aberrant promoter ...
 

Structure prediction with FAMS for proteins screened critically to autoimmune diseases based upon bioimformatics

  • 1. Structure prediction with FAMS for proteins screened critically to autoimmune diseases based upon bioimformatics Shigeharu Ishida (Dept. Phys., Chuo Uinv.) Hideaki Umeyama (Dept. Bio. Sci., Chuo Univ.) Mitsuo Iwadate (Dept. Bio. Sci., Chuo Univ.) Y-h. Taguchi (Dept. Phys., Chuo Uinv.)
  • 2. 1. Introduction Autoimmune disease: “Autoimmune disease arise from an inappropriate immune response of the body against substances and tissues normally present in the body.” Ex. Rheumatoid Arthritis (RA; 関節リウマチ) Alopecia areata (円形脱毛症)
  • 3. 2. Previous findings … B. M. Javierre et al (2010) Genome Res. 20[2] pp 170-179 Target: Systemic lupus erythematosus (SLE;全身性エリテマトーデス ) RA Dermatomyositis (DM;皮膚筋炎 ) Seek common promoter methylation → SLE Only
  • 4. Y-h. Taguchi, DMSM2010 (2010) http://www.ai-gakkai.or.jp/jsai/sig/dmsm/012/ Successfully picked up 33 promoters commonly methylated for RA, SLE, and DM. But, no biological validations ….. Data base : ☓ , Blast : ☓ In this paper, we show that protein structure prediction by FAMS is useful tool for functional annotation of proteins and also possibly useful for drug discovery...
  • 5. 3. FAMS (Full Automatic Modeling System) “The computer program FAMS performs homology modeling of protein structures by means of an algorithm consisting of database searches and simulated annealing.” Umeyama & Iwadate (2004) Curr Protoc Bioinformatics.
  • 6. 4. Results Reference Model genesymbol PDBID P-value gene symbol AIM2 2OQ0_B 4.00E-92 GAMMA-INTERFERON-INDUCIBLE PROTEIN IFI-16 CARD15 3CIY_B 7.00E-64 TOLL-LIKE RECEPTOR 4, VARIABLE LYMPHOCYTE (TLR4) CD82 2BG9_A 4.60E-01 ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA CHAIN CSF1R 3B43_A 5.00E-83 TITIN CSF3 1GNC_A 2.00E-66 GRANULOCYTE COLONY-STIMULATING FACTOR CSF3R 3DMK_A 1.00E-71 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) DHCR24 2Q4W_A 1.00E-115 CYTOKININ DEHYDROGENASE 7 (CKO7) ERCC3 2W74_D 1.00E-152 TYPE I RESTRICTION ENZYME ECOR124IIR PROTEIN (HSDR) GRB7 3HK0_B 2.00E-73 GROWTH FACTOR RECEPTOR-BOUNDP ROTEIN10 (GRB10) HGF 2F83_A 1.00E-111 COAGULATION FACTOR XI HOXB2 2D5V_A 9.00E-24 HEPATOCYTE NUCLEAR FACTOR 6 (HNF-6) IFNGR2 1FNF_A 1.00E-37 FIBRONECTIN LCN2 1X71_A 1.00E-51 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) LMO2 2XJY_A 2.00E-33 RHOMBOTIN-2 LTB4R 2KS9_A 2.00E-83 SUBSTANCE-P RECEPTOR MMP14 1SU3_B 1.00E-160 INTERSTITIAL COLLAGENASE (MMP-1) MMP8 1SU3_B 1.00E-171 INTERSTITIAL COLLAGENASE (MMP-1) MPL 3L5H_A 4.00E-63 INTERLEUKIN-6 RECEPTOR SUBUNIT BETA (IL6RB) PAD14 2DEW_ X 0.00E+00 PROTEIN-ARGININE DEIMINASE TYPE IV PECAM1 3DMK_A 1.00E-104 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) PI3 1TWP_A 2.00E-19 WHEY ACIDIC PROTEIN (WAP) RARA 3DZY_A 4.00E-95 RETINOIC ACID RECEPTOR RXR-ALPHA S100A2 2RGI_A 4.00E-19 PROTEIN S100-A2 SEPT9 3FTQ_A 1.00E-137 SEPTIN-2 SLC22A18 1PW4_A 1.00E-108 GLYCEROL-3-PHOSPHATE TRANSPORTER SPI1 1GVJ_B 1.00E-21 C-ETS-1 PROTEIN (ETS1) SPP1 1D2T_A 3.00E-14 ACID PHOSPHATASE (ACP) STAT5A 1Y1U_ A 0.00E+00 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT5A SYK 2OZO_A 1.00E-168 TYROSINE-PROTEIN KINASE ZAP-70 TIE1 3DMK_A 2.00E-84 DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) TM7SF3 [1AR1_A] 6.00E-88 CYTOCHROME C OXIDASE TRIP6 1B8T_A 2.00E-32 CYSTEINE-RICH PROTEIN1 (CRP1) VAMP8 2KOG_A 1.00E-21 VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 (VAMP2)
  • 7. ・Almost all proteins are modeled with very small P-values (〜10E-20) (with high significance) ・Obtained proteins have functional annotations (because they are listed in PDB) ⇒ Protein structure prediction by FAMS turns out to be also useful for functional annotation, because model protein registered in PDB is often well studied and annotated. (Otherwise none hope to decide 3D structure with much effort and money!)
  • 8. ・Almost all functional annotations are related to immunology/autoimmune ⇓ 33 selected promoters turned out to be biologically meaningful e.g., AIM2 modeled by IFI-16 “Structures of the HIN Domain: DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor” Jin et al (2012/4/20) Immunity.
  • 9. 5. To Drug Discovery... 5.1 Ligand Search mmp8/14 are modeled by mmp1. Ligand designed for mmp1 possibly can bind to mmp8/14, too. mmp8 mmp14
  • 10. 5.2 Search for protein complex Protein A Protein Complex Protein B in PDB Protein Complex Candidate
  • 11. Huge number of protein complex candidates were found.... CSF1R PECAM1 410
  • 12. CSF1R vs PECAM1 modeled by 2ZJS
  • 13. Why protein complex? If we can terminate protein complex formation by finding molecules to bind interface between two proteins, they can be drug.
  • 14. 6. Conclusion ・FAMS predicts protein structure of genes whose promoter are commonly de/methylated for autoimmune. ・Protein structure prediction is useful for functional annotation ・It also helps ligand search ・ FAMS is also useful protein complex inference which may lead to drug discovery